A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological Malignancies

NCT05990803 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: BL-B01D1
DRUG: SI-B003

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]